PME logo

Pro Medicus Limited Stock Price

ASX:PME Community·AU$18.8b Market Cap
  • 6 Narratives written by author
  • 8 Comments on narratives written by author
  • 210 Fair Values set on narratives written by author

PME Share Price Performance

AU$0
-328.25 (-100.00%)
AU$190.74
Fair Value
AU$0
-328.25 (-100.00%)
Price AU$0

PME Community Narratives

·
Fair Value AU$190.74 5.6% undervalued intrinsic discount

Cloud Imaging And AI Adoption Will Drive Long Term Healthcare Platform Dominance

0users have liked this narrative
0users have commented on this narrative
16users have followed this narrative
Fair Value
·
Fair Value AU$196.78 8.5% undervalued intrinsic discount

Pro Medicus: The Market Is Confusing a Lumpy Quarter With a Broken Business

22users have liked this narrative
8users have commented on this narrative
38users have followed this narrative
Fair Value
·
Fair Value AU$199.7 9.8% undervalued intrinsic discount

A stock I’m bullish on is Pro Medicus Limited (ASX: PME), an Australian healthcare technology company that develops medical imaging software

2users have liked this narrative
0users have commented on this narrative
11users have followed this narrative
AU$199.7
9.8% undervalued intrinsic discount
Fair Value
Revenue
17.32% p.a.
Profit Margin
97.56%
Future PE
59.07x
Price in 2031
AU$294.69
AU$196.78
8.5% undervalued intrinsic discount
Fair Value
Revenue
17.32% p.a.
Profit Margin
97.56%
Future PE
57.87x
Price in 2031
AU$288.69
AU$133.68
34.7% overvalued intrinsic discount
Fair Value
Revenue
-9.04% p.a.
Profit Margin
53.25%
Future PE
327.23x
Price in 2030
AU$191.26
AU$190.74
5.6% undervalued intrinsic discount
Revenue
23.55% p.a.
Profit Margin
57.2%
Future PE
95.91x
Price in 2029
AU$238.12
AU$300
40.0% undervalued intrinsic discount
Revenue
30.98% p.a.
Profit Margin
56.38%
Future PE
129.52x
Price in 2029
AU$377.57
AU$233.18
22.8% undervalued intrinsic discount
Revenue
26.01% p.a.
Profit Margin
55.36%
Future PE
129.33x
Price in 2029
AU$292.15

Trending Discussion

No trending discussion available.

Updated Narratives

PME logo

A stock I’m bullish on is Pro Medicus Limited (ASX: PME), an Australian healthcare technology company that develops medical imaging software

Fair Value: AU$199.7 9.8% undervalued intrinsic discount
11 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative
PME logo

Pro Medicus: The Market Is Confusing a Lumpy Quarter With a Broken Business

Fair Value: AU$196.78 8.5% undervalued intrinsic discount
38 users have set this as their fair value
8 users have commented on this narrative
0 users have liked this narrative
PME logo

Great Company.... but so expensive!

Fair Value: AU$133.68 34.7% overvalued intrinsic discount
21 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative

Snowflake Analysis

Flawless balance sheet with solid track record.

1 Risk
2 Rewards

Pro Medicus Limited Key Details

AU$240.6m

Revenue

AU$321.0k

Cost of Revenue

AU$240.2m

Gross Profit

AU$5.6m

Other Expenses

AU$234.7m

Earnings

Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
Aug 18, 2026
2.25
99.87%
97.56%
0%
View Full Analysis

About PME

Founded
1983
Employees
132
CEO
Sam Hupert
WebsiteView website
www.promed.com.au

Pro Medicus Limited, a healthcare informatics company, engages in the development and supply of healthcare imaging software, and radiology information (RIS) system software and services to hospitals, imaging centers, and health care groups in Australia, North America, and Europe. The company offers Visage RIS Visage 7 Enterprise Imaging Platform, a healthcare imaging software that provides radiologists, physicians, and clinicians with access and visualization capability for viewing 2-D, 3-D, and 4-D medical images; and picture archive and communication system (PACS)/digital imaging software. It also provides Visage RIS, a proprietary medical software for practice management, training, installation, professional services, and after-sale support and service products; and Promedicus.net, an e-health platform for secure email and integration products. In addition, the company offers Visage Ease, a mobile application that provides users access to medical imaging results; and Visage Ease Pro, a mobile application that provides users the ability to interpret various diagnostic imaging studies stored on a Visage 7 server. Pro Medicus Limited was incorporated in 1983 and is headquartered in Richmond, Australia.

Recent PME News & Updates

Narrative Update Jul 10

PME: Elevated Market Share Expectations Will Pressure Future Share Returns

Pro Medicus' analyst price target has been revised to A$192.60 from A$147.00, with analysts pointing to updated assumptions around long term market share in the US PACS segment and a reassessment of how much growth is already reflected in the current share price. What's in the News for Pro Medicus Pro Medicus has drawn renewed attention after a 33.15% share price decline over the past year, with recent commentary highlighting a valuation reset as a key factor in shifting sentiment.

Recent updates

No updates